Kayne Anderson Rudnick Investment Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-201
| Closed | -$2.01K | – | 978 |
|
|
2023
Q3 | $2.01K | Hold |
201
| – | – | ﹤0.01% | 688 |
|
|
2023
Q2 | $2.5K | Hold |
201
| – | – | ﹤0.01% | 665 |
|
|
2023
Q1 | $2.82K | Hold |
201
| – | – | ﹤0.01% | 616 |
|
|
2022
Q4 | $2.88K | Hold |
201
| – | – | ﹤0.01% | 632 |
|
|
2022
Q3 | $5K | Hold |
201
| – | – | ﹤0.01% | 583 |
|
|
2022
Q2 | $6K | Hold |
201
| – | – | ﹤0.01% | 554 |
|
|
2022
Q1 | $7K | Hold |
201
| – | – | ﹤0.01% | 545 |
|
|
2021
Q4 | $8K | Hold |
201
| – | – | ﹤0.01% | 546 |
|
|
2021
Q3 | $10K | Buy |
201
+101
| +101% | +$5.03K | ﹤0.01% | 518 |
|
|
2021
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 530 |
|
|
2021
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 524 |
|
|
2020
Q4 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 523 |
|